ANKTIVA
nogapendekin alfa inbakicept-pmln
Listed by Altor BioScience, LLC, an indirect wholly-owned subsidiary of ImmunityBio, Inc.
- Strength
- 400 ug/.4mL
- Form
- Solution
- Route
- Intravesical
- Class
- Interleukin-15 Receptor Agonist
What it contains
- Nogapendekin Alfa Inbakicept-pmln 400 ug/.4mL
FDA record
| Dosage form | Solution |
|---|---|
| Route | Intravesical |
| Drug class | Interleukin-15 Receptor Agonist |
| Approval route | BLA — biologic licence |
| NDC code | 81481-803 |
| FDA application | BLA761336 |
| RxNorm concept | 2682684 |
| Package sizes listed | 1 |
| Marketed since | May 2024 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.